Long Noncoding RNA PVT1 Promotes Hepatoblastoma Cell Proliferation Through Activating STAT3

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2019 Oct 2

PMID 31572006

Citations 17

Authors

Zhenqin Luo

Peiguo Cao

Affiliations

Soon will be listed here.

Abstract

Background: Hepatoblastoma is the most common liver malignancy in children. The long noncoding RNA (IncRNA) PVT1 plays oncogenic roles in human cancers; however, its regulation and function in hepatoblastoma remain poorly understood.

Purpose: This study was designed to investigate the regulation and function of PVT1 in hepatoblastoma.

Methods: PVT1 expression was compared between human hepatoblastoma tissues and adjacent non-tumor tissues, and then analyzed using Kaplan-Meier method. The proliferation of hepatoblastoma cells was determined by BrdU incorporation assay. The tumor xenograft model was used to assess tumor proliferation in vivo. The gene expression level was measured by qRT-pCR, Western blot and immunohistochemistry analyses.

Results: Compared with normal counterparts, PVT1 is upregulated in human hepatoblastoma tissues as well as in hepatoblastoma cell lines. Additionally, PVT1 promotes the proliferation of hepatoblastoma cells in vitro and accelerates tumor growth in xenograft model in vivo. Mechanistically, PVT1 promotes the activation of the signal transducer and activator of transcription 3 (STAT3), which leads to the transcriptional activation of downstream targets involved in cell cycle progression, and moreover,STAT3 inhibition with the selective inhibitor stattic abolishes PVT1 pro-proliferative role in hepatoblastoma cells.

Conclusion: PVT1 promotes hepatoblastoma cell proliferation through activating STAT3-induced cell cycle progression, which may implicate PVT1 as a potential therapeutic target for hepatoblastoma treatment.

Citing Articles

Summary of biological research on hepatoblastoma: a scoping review.

Wang H, Lao J, Jiang R, Wang B, Ma X, Wang J Front Pediatr. 2024; 12:1309693.

PMID: 38390281 PMC: 10881832. DOI: 10.3389/fped.2024.1309693.

The regulatory relationship between transcription factor STAT3 and noncoding RNA.

Liu S, Li W, Liang L, Zhou Y, Li Y Cell Mol Biol Lett. 2024; 29(1):4.

PMID: 38172648 PMC: 10763091. DOI: 10.1186/s11658-023-00521-1.

CRNDE: A Pivotal Oncogenic Long Non-Coding RNA in Cancers.

Hor Y, Salvamani S, Gunasekaran B, Yian K Yale J Biol Med. 2024; 96(4):511-526.

PMID: 38161583 PMC: 10751873. DOI: 10.59249/VHYE2306.

A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From mA Modification to Blood Biomarkers.

Eun J, Cheong J, Jeong J, Kim H Cells. 2023; 12(18).

PMID: 37759495 PMC: 10528438. DOI: 10.3390/cells12182272.

LncRNA SATB2-AS1 overexpression represses the development of hepatocellular carcinoma through regulating the miR-3678-3p/GRIM-19 axis.

Huang J, Yang Y, Zhao F, Zhang Z, Deng J, Lu W Cancer Cell Int. 2023; 23(1):82.

PMID: 37118800 PMC: 10148439. DOI: 10.1186/s12935-023-02901-1.

References

Yu H, Lee H, Herrmann A, Buettner R, Jove R . Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014; 14(11):736-46. DOI: 10.1038/nrc3818. View

Cui M, You L, Ren X, Zhao W, Liao Q, Zhao Y . Long non-coding RNA PVT1 and cancer. Biochem Biophys Res Commun. 2016; 471(1):10-4. DOI: 10.1016/j.bbrc.2015.12.101. View

Wan L, Sun M, Liu G, Wei C, Zhang E, Kong R . Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression. Mol Cancer Ther. 2016; 15(5):1082-94. DOI: 10.1158/1535-7163.MCT-15-0707. View

Purcell R, Childs M, Maibach R, Miles C, Turner C, Zimmermann A . Potential biomarkers for hepatoblastoma: results from the SIOPEL-3 study. Eur J Cancer. 2011; 48(12):1853-9. DOI: 10.1016/j.ejca.2011.10.019. View

Zhang Z, Liu F, Yang F, Liu Y . Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1. Biomed Pharmacother. 2018; 101:14-23. DOI: 10.1016/j.biopha.2018.02.026. View

Zhuang C, Li J, Liu Y, Chen M, Yuan J, Fu X . Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells. Oncotarget. 2015; 6(38):41194-203. PMC: 4747399. DOI: 10.18632/oncotarget.5880. View

Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, Tanida I . Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 2010; 7(2):176-87. PMC: 3039768. DOI: 10.4161/auto.7.2.14074. View

Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A . The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol. 2007; 213(2):511-8. DOI: 10.1002/jcp.21133. View

Aggarwal B, Kunnumakkara A, Harikumar K, Gupta S, Tharakan S, Koca C . Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci. 2009; 1171:59-76. PMC: 3141289. DOI: 10.1111/j.1749-6632.2009.04911.x. View

10.

Iden M, Fye S, Li K, Chowdhury T, Ramchandran R, Rader J . The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis. PLoS One. 2016; 11(5):e0156274. PMC: 4883781. DOI: 10.1371/journal.pone.0156274. View

11.

Colombo T, Farina L, Macino G, Paci P . PVT1: a rising star among oncogenic long noncoding RNAs. Biomed Res Int. 2015; 2015:304208. PMC: 4391155. DOI: 10.1155/2015/304208. View

12.

Bollrath J, Phesse T, von Burstin V, Putoczki T, Bennecke M, Bateman T . gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 2009; 15(2):91-102. DOI: 10.1016/j.ccr.2009.01.002. View

13.

Trobaugh-Lotrario A, Katzenstein H . Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies. Pediatr Blood Cancer. 2012; 59(5):809-12. DOI: 10.1002/pbc.24219. View

14.

Trobaugh-Lotrario A, Meyers R, ONeill A, Feusner J . Unresectable hepatoblastoma: current perspectives. Hepat Med. 2017; 9:1-6. PMC: 5293365. DOI: 10.2147/HMER.S89997. View

15.

Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View

16.

Ding C, Yang Z, Lv Z, Du C, Xiao H, Peng C . Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients. Oncol Lett. 2015; 9(2):955-963. PMC: 4301564. DOI: 10.3892/ol.2014.2730. View

17.

Cui D, Yu C, Liu M, Xia Q, Zhang Y, Jiang W . Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer. Tumour Biol. 2015; 37(3):4127-34. DOI: 10.1007/s13277-015-4261-x. View

18.

Barsotti A, Beckerman R, Laptenko O, Huppi K, Caplen N, Prives C . p53-Dependent induction of PVT1 and miR-1204. J Biol Chem. 2011; 287(4):2509-19. PMC: 3268411. DOI: 10.1074/jbc.M111.322875. View

19.

Bromberg J, Wrzeszczynska M, Devgan G, Zhao Y, Pestell R, Albanese C . Stat3 as an oncogene. Cell. 1999; 98(3):295-303. DOI: 10.1016/s0092-8674(00)81959-5. View

20.

Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H . Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer. 2013; 110(1):164-71. PMC: 3887297. DOI: 10.1038/bjc.2013.698. View